First Time Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 27.465 EUR -0.24% Market Closed
Updated: Jul 27, 2024
Have any thoughts about
Bayer AG?
Write Note

Relative Value

The Relative Value of one BAYN stock under the Base Case scenario is 88.603 EUR. Compared to the current market price of 27.465 EUR, Bayer AG is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAYN Relative Value
Base Case
88.603 EUR
Undervaluation 69%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
81
Median 3Y
1
Median 5Y
1.1
Industry
2.4
Forward
0.6
vs History
vs Industry
40
Median 3Y
11.4
Median 5Y
10.8
Industry
21.7
Forward
5.2
vs History
95
vs Industry
47
Median 3Y
8.4
Median 5Y
7.5
Industry
16.1
vs History
50
vs Industry
31
Median 3Y
10.1
Median 5Y
8.9
Industry
22.5
vs History
95
vs Industry
68
Median 3Y
1.4
Median 5Y
1.3
Industry
2
vs History
90
vs Industry
67
Median 3Y
1.6
Median 5Y
1.7
Industry
2.5
Forward
1.2
vs History
90
vs Industry
70
Median 3Y
2.7
Median 5Y
2.8
Industry
5
vs History
66
vs Industry
45
Median 3Y
6.5
Median 5Y
6.5
Industry
13.3
Forward
5.4
vs History
3
vs Industry
5
Median 3Y
11.3
Median 5Y
11
Industry
16.6
Forward
8.3
vs History
90
vs Industry
39
Median 3Y
12.7
Median 5Y
11.5
Industry
15.1
vs History
74
vs Industry
24
Median 3Y
18.4
Median 5Y
17.4
Industry
18.1
vs History
95
vs Industry
74
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

BAYN Competitors Multiples
Bayer AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Bayer AG
XETRA:BAYN
27B EUR 0.6 -8.7 5.3 76.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
764.7B USD 21.3 124.6 60.9 69.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 15.9 43.6 32.5 35.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
386.6B USD 4.5 10.2 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
317.2B USD 5.2 137.6 34.4 56.1
CH
Roche Holding AG
SIX:ROG
228B CHF 3.9 19.8 11.1 13.2
UK
AstraZeneca PLC
NASDAQ:AZN
243.8B USD 5.1 38.5 19.3 30.7
CH
Novartis AG
SIX:NOVN
190.7B CHF 4.4 13.4 10.6 15.7
US
Pfizer Inc
NYSE:PFE
174.4B USD 3.2 -564.3 13.4 21.7
P/E Multiple
Earnings Growth
DE
Bayer AG
XETRA:BAYN
Average P/E: 55.4
Negative Multiple: -8.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
124.6
340%
DK
Novo Nordisk A/S
CSE:NOVO B
43.6
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10.2
-21%
US
Merck & Co Inc
NYSE:MRK
137.6
7 578%
CH
Roche Holding AG
SIX:ROG
19.8
28%
UK
A
AstraZeneca PLC
NASDAQ:AZN
38.5
172%
CH
Novartis AG
SIX:NOVN
13.4
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -564.3
683%

See Also

Discover More